MedPath

Study on the central mechanism and prediction of efficacy of acupuncture in the treatment of chronic insomnia disorder

Not Applicable
Not yet recruiting
Conditions
chronic insomnia disorder
Registration Number
ITMCTR2200005885
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Gender unlimited, right-handed;
2. Age: 18 years = age = 60 years;
3. Pittsburgh sleep quality index (PSQI) score > 7 and Montreal Cognitive Assessment (MoCA)=24;
4. Insomnia symptoms 3 times a week for more than 3 months: including difficulty falling asleep, not sleeping deep or waking early; Sleep disturbances cause clinically significant distress;
5. Not taking hypnotics and other psychotropic drugs within 2 weeks before enrollment;
6. Informed consent was signed by the patient himself or by his / her immediate family.
Note: patients who meet each of the above criteria may be included in this study.

Exclusion Criteria

1. History of disorders of consciousness;
2. Other types of sleep disorders, including sleep apnea syndrome, sleep related movement disorders, central sleep disorders, narcolepsy and sleep wake rhythm disorders, etc;
3. Combined severe heart, liver, kidney, brain and hematopoietic diseases;
4. Have a history of depression, bipolar disorder, schizophrenia and other psychiatric disorders;
5. Pregnant and lactating women; Those with willingness to conceive in nearly three months;
6. History of alcohol, drugs, coffee dependence;
7. Contraindications to MRI scanning such as electronic versus metallic device implantation.
Note: patients who met any of the above were excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.